Free Newsletter
Wellcome Trust plans spike in research spending
The UK's Wellcome Trust says it will pump up its research spending by 60 percent over the next five years as it ambitiously seeks a better understanding of diseases at a genetic level. The funding spike--to £4 billion-backs a range of research projects, including the Biobank project, which is seeking a greater understanding of genetics and environmental factors as well as the Case Control Consortium, which hunts for genes involved in disease.
"One of our priorities is to increase our understanding of common human diseases at the genetic level," Wellcome chief Dr Mark Walport told the BBC. "Developments in technology have meant we can now do this kind of science on a scale that we've not been able to before."
- see this release
- read the article from the BBC
ALSO: President Bush's new budget is keeping the NIH's funding at an even level, a fact that quickly aroused protests from groups that have been harshly critical of the long-term effects of flat-line research budgets. Report
Related Articles:
Research group mapping 1,000 genomes. Report
Cells prompted to "eat" Huntington proteins. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: